A paradigm shift in the surgical treatment of cancer
Next-generation miniaturized sensors
Power of AI to combine diagnostic and surgical images
New breakthrough cancer-targeted imaging agents
We are using next-generation miniaturized sensors to enable the engineering of miniaturized probes suitable in scale for the small laparoscopic ports used in state-of-the-art robotic surgery
New breakthrough cancer-targeted imaging agents
Power of AI to combine diagnostic and surgical images
New breakthrough cancer-targeted imaging agents
Combined with new cancer-targeted imaging agents, such as PSMA, our probes can define entirely novel radio-guided surgical applications, promising a paradigm shift in the surgical treatment of cancer
Power of AI to combine diagnostic and surgical images
Power of AI to combine diagnostic and surgical images
Power of AI to combine diagnostic and surgical images
By using the same cancer-target imaging agents, data from pre-operative scans along with intra-operative data from Lightpoint’s probes can be combined with AI to offer never-seen-before visualization of the surgical location and extent of any cancer
Improving outcomes for patients
Power of AI to combine diagnostic and surgical images
Power of AI to combine diagnostic and surgical images
All aiding surgeons to find and remove cancer, transforming outcomes for patients and saving costs for healthcare systems
The incidence of cancer is growing rapidly worldwide
+18 million
Lack of tools to accurately detect cancer intraoperatively
Rising over 60% by 2030
+18 million new cases of cancer will be diagnosed globally and the disease will account for one in six deaths
Rising over 60% by 2030
Lack of tools to accurately detect cancer intraoperatively
Rising over 60% by 2030
The incidence of cancer is forecast to rise by over 60% by 2030 with over 24 million new cases each year worldwide
Robots have transformed surgery
Lack of tools to accurately detect cancer intraoperatively
Lack of tools to accurately detect cancer intraoperatively
Robots have transformed surgery in recent decades with minimally-invasive, robot-assisted cancer surgery now dominating clinical practice
Lack of tools to accurately detect cancer intraoperatively
Lack of tools to accurately detect cancer intraoperatively
Lack of tools to accurately detect cancer intraoperatively
However, despite the robotic advances, cancer is often left behind or, conversely, healthy tissue is needlessly removed, increasing the need for further drug treatment, radiotherapy, & surgery
Latest news
SENSEI® named Best New Surgical Technology Solution 2022
New SENSEI® study launched in robot-assisted colorectal cancer surgery
New SENSEI® study launched in robot-assisted colorectal cancer surgery
SENSEI® has been selected as the winner of the Best New Surgical Technology Solution in the 2022 MedTech Breakthrough Awards
New SENSEI® study launched in robot-assisted colorectal cancer surgery
New SENSEI® study launched in robot-assisted colorectal cancer surgery
New SENSEI® study launched in robot-assisted colorectal cancer surgery
Professor Manish Chand launches clinical feasibility study using SENSEI® in robot-assisted colorectal cancer surgery at University College Hospital, London.
First SENSEI® procedure in lung surgery and first use in the US
New SENSEI® study launched in robot-assisted colorectal cancer surgery
First SENSEI® procedure in lung surgery and first use in the US
Dr Doug Adams, Bethesda North Hospital, Cincinnati, Ohio (part of TriHealth), performs the first SENSEI® procedures in lung surgery and first use in the US.